Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft Clinical Trials Info presented on Clinical Trials Search isn't intended to be a substitute for certified medical advice, calls or professional assistance using a genuine dr.. We aren't physicians. Always confer with your dr. on Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft conditions. Clinical Trials Search.org is a website committed to listing clinical research studies in human subjects. Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft Clinical research trials and Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft medical trials happen in hundreds of localities throughout the U.S.A.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically measure the effectualness of new does drugs. The intent of the studies / undertakings is to answer particular human health questions. Clinical trials are a popular manner for physicians, government agencies, and private sector corporations to find cures for all kinds of circumstances, like Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft. Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft Clinical Trials and other clinical trials permit volunteers to acquire healthcare treatment options before they are available to the general public. Some times the subjects acquire professional assistance for free, and sometimes they are paid for their time. Sometimes there is a cost for a Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft clinical trial. Participants frequently obtain the most expert healthcare available for their Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft condition. Dangers are a reality, nevertheless, and can include more or frequent doctor calls, health risks (potentially life-jeopardizing), and/or the treatment being ineffectual. Trials are federally regulated with strict guidelines to protect clinical trials subjects.

Home > "E" Clinical Trials Conditions > Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft

Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft



Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft

For Condition: Critical Limb Ischemia following Bypass Graft
Status: Recruiting
Sponsor(s): United Therapeutics ,
Synopsis: Approximately 30 patients will be enrolled in this 12-week study designed to assess the effect of continuous subcutaneous Remodulin therapy on the outcome of infrainguinal bypass grafts in patients with CLI. Portions of the study will be conducted in the hospital and on an out-patient basis. The study will be conducted at multiple centers.
Details:
Eligibility:
Study Type:
  Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/85 Years
Genders: Both
Protocol Entry Criteria: Patients with critical limb ischemia and an appropriate reference lower-limb ischemic wound due to documented peripheral arterial disease who have had an autogenous vein infrainguinal bypass graft performed immediately prior to study initiation.
Total Enrollment: 30

Location and Contact Information:

Vascular Institute Albany Medical College *Recruiting*
Albany,  New York,  12208
United States
Recruiting Debbie  Hill 518-262-5021

Southern Illinois University School of Medicine *Recruiting*
Springfield,  Illinois,  62702
United States
Recruiting Carol  Buettner 217-545-2320

Oregon Health Sciences University *Recruiting*
Portland,  Oregon,  97239
United States
Recruiting Rakhee  Urankar 503-494-4334

University of Massachusetts Memorial Health Center *Recruiting*
Worcester,  Massachusetts,  01655
United States
Recruiting Mary  Martella 508-856-6834


Additional Information:
Study ID Numbers:
  REM03:203; 
Study Start Date: March 2003
Record last reviewed: August 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00067041

Other Critical Limb Ischemia Following Bypass Graft Studies:
1. Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft

Related Studies:

Other Critical Limb Ischemia following Bypass Graft Clinical Trials
Other Illinois Clinical Trials
Other Springfield Clinical Trials

Effects of Remodulin in Patients with Critical Limb Ischemia Following a Vein Bypass Graft

Modify your Search

  Other Critical Limb Ischemia following Bypass Graft Clinical Trials
  Other Illinois Clinical Trials
  Other Springfield Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103